The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Jul 2022)
Editorial: Cyclic Nucleotide Phosphodiesterases (PDEs) in Immune Regulation and Inflammation
Stefan Brocke,
Paul M. Epstein,
Robert Nelson,
Tim Vanmierlo,
Tim Vanmierlo
Affiliations
Stefan Brocke
Department of Immunology, UConn Health, Farmington, CT, United States
Paul M. Epstein
Department of Cell Biology, UConn Health, Farmington, CT, United States
Robert Nelson
MindImmune Inc and University of Rhode Island, Kingston, RI, United States
Tim Vanmierlo
Hasselt University, Hasselt, Belgium
Tim Vanmierlo
Maastricht University, Maastricht, Netherlands
DOI
https://doi.org/10.3389/fphar.2022.950480
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
3′,5′-cyclic nucleotide phosphodiesterase
cell signaling
therapeutic targets
small molecule inhibitor
inflammation
WeChat QR code
Close